Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 27Neoplasm Metastasis 8Colonic Neoplasms 7Rectal Neoplasms 5Pancreatic Neoplasms 4Stomach Neoplasms 3Neoplasms 3Carcinoma, Neuroendocrine 2Pancreatic Adenocarcinoma Metastatic 1Metastatic Pancreatic Ductal Adenocarcinoma 1Metastatic Colorectal Adenocarcinoma 1Margins of Excision 1Liver Metastasis Colon Cancer 1Gastroesophageal Adenocarcinoma 1CRC 1Advanced Gastric or EGJ Cancer 1Adenocarcinoma 1

Interventions

Bevacizumab 2regorafenib 1Radiofrequency Ablation 1Oxaliplatin 1IFL protocol 1FOLFOXIRI protocol 1Electroporation 1Cetuximab 1CPG-oligonucleotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Metastasis Colon Cancer × IFL protocol × Clear all
NCT04003792 2020-10-20

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Rabin Medical Center

Phase 2 Unknown
49 enrolled
Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡